| Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions. | |
| | |
MedLine Citation:
|
PMID: 19079619 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Human papilloma virus (HPV) infection of the uterine cervix is linked to the pathogenesis of cervical cancer. Preclinical in vitro and in vivo studies using HPV-containing human cervical carcinoma cell lines have shown that the mammalian target of rapamycin (mTOR) inhibitor, rapamycin, and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor, erlotinib, can induce growth delay of xenografts. Activation of Akt and mTOR are also observed in cervical squamous cell carcinoma and, the expression of phosphorylated mTOR was reported to serve as a marker to predict response to chemotherapy and survival of cervical cancer patients. Therefore, we investigated: a) the expression level of EGFR in cervical squamous cell carcinoma (SCC) and high-grade squamous intraepithelial lesions (HSIL) versus non-neoplastic cervical squamous epithelium; b) the state of activation of the mTOR pathway in these same tissues; and c) any impact of these signal transduction molecules on cell cycle. Formalin-fixed paraffin-embedded tissue microarray blocks containing 20 samples each of normal cervix, HSIL and invasive SCC, derived from a total of 60 cases of cervical biopsies and cervical conizations were examined. Immunohistochemistry was utilized to detect the following antigens: EGFR; mTOR pathway markers, phosphorylated (p)-mTOR (Ser2448) and p-p70S6K (Thr389); and cell cycle associated proteins, Ki-67 and S phase kinase-associated protein (Skp)2. Protein compartmentalization and expression were quantified in regard to proportion (0-100%) and intensity (0-3+). Mitotic index (MI) was also assessed. An expression index (EI) for pmTOR, p-p70S6K and EGFR, respectively was calculated by taking the product of intensity score and proportion of positively staining cells. We found that plasmalemmal EGFR expression was limited to the basal/parabasal cells (2-3+, EI = 67) in normal cervical epithelium (NL), but was diffusely positive in all HSIL (EI = 237) and SCC (EI 226). The pattern of cytoplasmic p-mTOR and nuclear p-p70S6K expression was similar to that of EGFR; all showed a significantly increased EI in HSIL/SCC versus NL (p<0.02). Nuclear translocation of p-mTOR was observed in all SCC lesions (EI = 202) and was significantly increased versus both HSIL (EI = 89) and NL (EI = 54) with p<0.015 and p<0.0001, respectively. Concomitant increases in MI and proportion of nuclear Ki-67 and Skp2 expression were noted in HSIL and SCC. In conclusion, morphoproteomic analysis reveals constitutive activation and overexpression of the mTOR pathway in HSIL and SCC as evidenced by: increased nuclear translocation of pmTOR and p-p70S6K, phosphorylated at putative sites of activation, Ser2448 and Thr389, respectively; correlative overexpression of the upstream signal transducer, EGFR, and increases in cell cycle correlates, Skp2 and mitotic indices. These results suggest that the mTOR pathway plays a key role in cervical carcinogenesis and targeted therapies may be developed for SCC as well as its precursor lesion, HSIL. |
| | |
Authors:
|
Wei Feng; Xiuzhen Duan; Jinsong Liu; Jianguo Xiao; Robert E Brown |
Related Documents
:
|
20160029 - Her kinase axis receptor dimer partner switching occurs in response to egfr tyrosine ki... 18460189 - Diesel exhaust increases egfr and phosphorylated c-terminal tyr 1173 in the bronchial e... 20832399 - Acute ligand-independent src activation mimics low egf-induced egfr surface signalling ... 20432069 - Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of recepto... 15626689 - Pge2-induced hypertrophy of cardiac myocytes involves ep4 receptor-dependent activation... 16419029 - The mek/mapk pathway is involved in the resistance of breast cancer cells to the egfr t... 15067039 - Cutting edge: the ontogeny and function of va14ja18 natural t lymphocytes require signa... 14592419 - Possible involvement of a cyclic amp-dependent mechanism in pacap-induced proliferation... 15302569 - Unbalanced activation of erk1/2 and mek1/2 in apigenin-induced hela cell death. |
Publication Detail:
|
Type: Journal Article Date: 2008-10-02 |
Journal Detail:
|
Title: International journal of clinical and experimental pathology Volume: 2 ISSN: 1936-2625 ISO Abbreviation: - Publication Date: 2009 |
Date Detail:
|
Created Date: 2008-12-16 Completed Date: 2010-01-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101480565 Medline TA: Int J Clin Exp Pathol Country: United States |
Other Details:
|
Languages: eng Pagination: 249-60 Citation Subset: - |
Affiliation:
|
Department of Pathology, The University of Texas Medical School at Houston, Houston, TX, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A Morphometric Study of Antral G-Cell Density in a Sample of Adult General Population: Comparison of...
Next Document: Cost-Effectiveness of Active versus Conservative Colposcopic Management of Mild Dyskaryosis.